Sanjay Patal

SpineThera, Inc. engages in the designs and development of injectable drugs to meet the requirements for administration in and near the spine. Its product include SX600, an investigational drug. The company was founded by Jeffrey Missling and is headquartered in Plymouth, MN.

Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland.

Norwich Pharmaceuticals Inc. provides contract manufacturing and clinical services for the pharmaceuticals industry. It offers services, including clinical trial production support, quality assurance and control and regulatory compliance. The company was founded in 1887 and is headquartered in Norwich, NY.

Part of Alvogen, Inc., Alvogen Group, Inc. is a pharmaceutical company that offers a unique portfolio of high-quality and difficult-to-make pharmaceutical products. The company is based in Pine Brook, NJ. The company's targeted growth strategy is fueled by providing affordable generic medications that help reduce healthcare costs globally.

Tedor Pharma, Inc. operates as a pharmaceutical company. It develops oral solid dose products. The firm offers development and manufacturing, formulation, laboratory, and analytical services. The company was founded in 2001 and is headquartered in Cumberland, RI.

Cybin Corp. engages in psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols that target psychiatric and neurological conditions. The company was founded by Paul Glavine, Eric So, and John Kanakis and is headquartered in Toronto, Canada.

Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA.

Cybin IRL Ltd. is a leading ethical biopharmaceutical company based in North Wall Quay, Ireland. The Irish company works with a network of world-class partners and internationally-recognized scientists to create safe and effective therapeutics for patients, specifically targeting a range of mental health issues. The CEO of the company is Douglas L. Drysdale.